SlateStone Wealth LLC Raises Stock Holdings in Colgate-Palmolive (NYSE:CL)

SlateStone Wealth LLC boosted its holdings in Colgate-Palmolive (NYSE:CL) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,873 shares of the company’s stock after buying an additional 375 shares during the quarter. SlateStone Wealth LLC’s holdings in Colgate-Palmolive were worth $988,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of CL. Diamond Hill Capital Management Inc. purchased a new position in Colgate-Palmolive in the 4th quarter worth about $348,718,000. FMR LLC grew its stake in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the period. AMF Tjanstepension AB grew its stake in shares of Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after purchasing an additional 2,353,268 shares during the period. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. Finally, State Street Corp grew its stake in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Trading Down 0.8 %

CL stock opened at $89.80 on Monday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market capitalization of $72.87 billion, a price-to-earnings ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40. The business has a 50 day simple moving average of $89.02 and a two-hundred day simple moving average of $94.67.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business posted $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.